| Effect | Increase |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 14 |
| Sex | Both Genders |
| Age Range | 45-64, 65+ |
| Body Types | Overweight |
A reduction in triglycerides (27%) and vLDL were met with an increase in LDL-C (6%) and no significant influence on fasting HbA1c or glucose in type II diabetics given fish oil at 1,800mg EPA and 1,200mg DHA for 8 weeks. The activity of plasminogen inhibitor 1 increased 21%
